Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB00486_nanopub.RACZu0mnFjBI4Ozfd64NXsdhwVuSrORQoDU2uDtZ0aTrc#assertion>. }
Showing items 1 to 24 of
24
with 100 items per page.
- drugbank:DB00486 type drugbank_vocabulary:Drug assertion.
- drugbank:DB00486 label "Nabilone [drugbank:DB00486]" assertion.
- drugbank:DB00486 seeAlso DB00486 assertion.
- drugbank:DB00486 seeAlso nabilone.html assertion.
- drugbank:DB00486 identifier "drugbank:DB00486" assertion.
- drugbank:DB00486 description "Nabilone is a synthetic cannabinoid with therapeutic use as an antiemetic and as an adjunct analgesic for neuropathic pain. It is a synthetic cannabinoid, which mimics the main ingredient of marijuana (THC) but it has more predictable side effects and causes no or minimal euphoria. Nabilone is not derived from the cannabis plant as is dronabinol. In Canada, the United States, the United Kingdom and Mexico, nabilone is marketed as Cesamet. It was approved in 1985 by the United States FDA for treatment of chemotherapy-induced nausea and vomiting that has not responded to conventional antiemetics. Though it was approved by the FDA in 1985, the drug only began marketing in the United States in 2006. It is also approved for use in treatment of anorexia and weight loss in patients with AIDS. Although it doesn't have the official indication (except in Mexico), nabilone is widely used as an adjunct therapy for chronic pain management. Numerous trials and case studies have demonstrate various benefits for condition such as fibromyalgia and multiple scerosis. Nabilone is a racemate consisting of the (S,S) and the (R,R) isomers ("trans")." assertion.
- drugbank:DB00486 title "Nabilone" assertion.
- drugbank:DB00486 bio2rdf_vocabulary:identifier "DB00486" assertion.
- drugbank:DB00486 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB00486 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB00486" assertion.
- drugbank:DB00486 bio2rdf_vocabulary:x-identifiers.org DB00486 assertion.
- drugbank:DB00486 drugbank_vocabulary:drugbank-id "APRD01127" assertion.
- drugbank:DB00486 drugbank_vocabulary:drugbank-id "DB00486" assertion.
- drugbank:DB00486 drugbank_vocabulary:x-cas cas:51022-71-0 assertion.
- drugbank:DB00486 drugbank_vocabulary:x-chemspider chemspider:4447641 assertion.
- drugbank:DB00486 drugbank_vocabulary:x-pubchemcompound pubchem.compound:5284592 assertion.
- drugbank:DB00486 drugbank_vocabulary:x-pubchemsubstance pubchem.substance:46505171 assertion.
- drugbank:DB00486 drugbank_vocabulary:x-ahfs ahfs:56:22.92 assertion.
- drugbank:DB00486 drugbank_vocabulary:x-atc atc:A04AD11 assertion.
- drugbank:DB00486 drugbank_vocabulary:x-dpd dpd:2256193 assertion.
- drugbank:DB00486 drugbank_vocabulary:x-kegg kegg:D05099 assertion.
- drugbank:DB00486 drugbank_vocabulary:x-pharmgkb pharmgkb:PA164746998 assertion.
- drugbank:DB00486 drugbank_vocabulary:x-wikipedia wikipedia:Nabilone assertion.
- drugbank:DB00486 drugbank_vocabulary:x-ndc ndc:0187-1221-03 assertion.